FindTrial
Sign In

Study on the evaluation of clinical efficacy of liver depression syndrome in breast cancer

Study on the evaluation of clinical efficacy of liver depression syndrome in breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025001756
Enrollment
Unknown
Registered
2025-09-15
Start date
2025-05-06
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Observation Group:NA

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Pathology meets the diagnostic criteria for breast cancer; (2) TCM evidence and diagnosis meets the diagnostic criteria of Liver Depression Diagnosis of Breast Cancer; (3) Female patients older than 18 years old (including 18 years old); (4) ECOG (Eastern cooperative oncology group) score of 0-2; (5) Voluntary participation in the study and signing an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with combined serious cardiovascular cerebrovascular or psychiatric-related diseases; (2) Patients with complications from breast cancer treatment such as postoperative wound infection severe lymphedema neutropenic fever or radiation pneumonitis; (3) Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Signs and symptoms Chinese medicine syndromes and Chinese herbal formulas;—

Countries

China

Contacts

Public ContactQianqian Guo

Guangdong Provincial Hospital of Chinese Medicine

guoqianqian@gzucm.edu.cn15915740853

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026